Osimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib Treatment
Clinical trial NCT04438902 · TERMINATED
Trial details
- NCT number
- NCT04438902
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-12
- Primary completion
- 2022-12-08
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.